🇺🇸 FDA
Patent

US 7723303

Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

granted A61KA61K38/00A61P

Quick answer

US patent 7723303 (Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response) held by The Regents of the University of California expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/00, A61P, A61P25/28, A61P31/04